Marex Group PLC (MRX) — SEC Filings

Overview

Marex Group PLC (MRX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a FWP filed on Apr 16, 2026: Marex Group plc filed a Free Writing Prospectus (FWP) on April 16, 2026, under Securities Act Rules 163/433. The filing, with accession number 0001193125-26-159321, pertains to their business as Security & Commodity Brokers, Dealers, Exchanges & Services.

Sentiment Summary

Across 42 filings, the sentiment breakdown is: 1 bullish, 41 neutral. The dominant filing sentiment for Marex Group PLC is neutral.

Filing Type Overview

Marex Group PLC (MRX) has filed 5 424B2, 1 FWP, 10 13F-HR, 23 6-K, 1 20-F, 2 SC 13G with the SEC between May 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (42)

• 424B2 Filing — 424B2 · Apr 17, 2026
• Marex Group plc Files Free Writing Prospectus — FWP · Apr 16, 2026 Risk: low
  Marex Group plc filed a Free Writing Prospectus (FWP) on April 16, 2026, under Securities Act Rules 163/433. The filing, with accession number 0001193125-26-159
• 13F-HR Filing — 13F-HR · Apr 7, 2026
• 13F-HR Filing — 13F-HR · Apr 2, 2026
• 13F-HR Filing — 13F-HR · Apr 2, 2026
• 13F-HR Filing — 13F-HR · Apr 2, 2026
• 13F-HR Filing — 13F-HR · Apr 2, 2026
• 13F-HR Filing — 13F-HR · Apr 2, 2026
• 13F-HR Filing — 13F-HR · Apr 2, 2026
• 13F-HR Filing — 13F-HR · Apr 2, 2026
• Marex Group plc Files Prospectus Supplement — 424B2 · Apr 1, 2026 Risk: low
  Marex Group plc filed a 424B2 prospectus supplement on April 1, 2026, related to its securities. The filing includes pricing supplement documents and graphic fi
• Marex Group plc Files 424B2 Prospectus Supplement — 424B2 · Apr 1, 2026 Risk: low
  Marex Group plc filed a 424B2 prospectus supplement on April 1, 2026, related to its securities. The filing includes pricing supplement documents and graphics,
• 424B2 Filing — 424B2 · Apr 1, 2026
• Marex Group plc Files 424B2 Prospectus Supplement — 424B2 · Mar 31, 2026 Risk: low
  Marex Group plc filed a 424B2 prospectus supplement on March 31, 2026, related to its securities. The filing includes pricing supplement documents and exhibits,
• Marex Group Files 6-K for Q1 2026, Signals Upcoming Financial Update — 6-K · Mar 26, 2026
  Marex Group plc, a security and commodity broker, filed a 6-K report on March 26, 2026, indicating a period of report ending March 31, 2026. This filing include
• Marex Group Files 2025 Annual Report (6-K) — 6-K · Mar 25, 2026
  Marex Group plc filed a 6-K report on March 25, 2026, for the period ending December 31, 2025. This filing includes their annual report (EX-99.1) and numerous s
• 13F-HR Filing — 13F-HR · Nov 14, 2025
• Marex Group plc Reports Q3 2025 Results — 6-K · Nov 6, 2025 Risk: low
  Marex Group plc announced its third quarter 2025 results on November 6, 2025. The company, headquartered in London, filed a Form 6-K report with the SEC detaili
• Marex Directors & Officers Buy Company Shares — 6-K · Oct 15, 2025 Risk: low
  On October 15, 2025, Marex Group plc announced that its Directors and Officers purchased ordinary shares. The press release detailing these transactions is furn
• Marex CEO Buys Shares — 6-K · Oct 14, 2025 Risk: low
  On October 13, 2025, Marex Group plc announced that its Chief Executive Officer purchased ordinary shares. The company is a global financial services firm speci
• Marex Group plc: Strong Preliminary Q3 2025 Trading Update — 6-K · Oct 8, 2025 Risk: low
  Marex Group plc announced a strong preliminary Q3 2025 trading update on October 8, 2025. The company, headquartered in London, provided this update via a press
• 13F-HR Filing — 13F-HR · Aug 19, 2025
• Marex Group plc Reports Interim 2025 Results — 6-K · Aug 13, 2025 Risk: low
  Marex Group plc announced its Interim 2025 Results on August 13, 2025, covering the six months ended June 30, 2025. The company, headquartered in London, filed
• Marex Group plc Files 6-K, Incorporates into S-8 and F-3 Filings — 6-K · May 30, 2025 Risk: low
  Marex Group plc filed a Form 6-K on May 30, 2025, to report information for the month of May 2025. This filing is incorporated by reference into their existing
• Marex Group Director Resigns — 6-K · May 15, 2025 Risk: low
  Marex Group plc announced on May 13, 2025, that Roger Nagioff resigned from its Board of Directors, effective immediately. Mr. Nagioff, who represented private
• Marex Group plc Reports Strong Q1 2025 Results — 6-K · May 15, 2025 Risk: low
  Marex Group plc announced strong results for the first quarter of 2025 on May 15, 2025. The company, headquartered in London, United Kingdom, filed a Form 6-K t
• Marex Group plc Issues $500M in Senior Notes Due 2028 — 6-K · May 8, 2025 Risk: medium
  On May 8, 2025, Marex Group plc completed a public offering of $500,000,000 in aggregate principal amount of its 5.829% Senior Notes due 2028. This offering was
• Marex Group plc Updates 20-F Filing — 6-K · May 1, 2025 Risk: low
  Marex Group plc filed a Form 6-K on May 1, 2025, to update its Annual Report on Form 20-F, originally filed on March 21, 2025. The updates pertain to the 'Busin
• Marex Group Director Resigns — 6-K · Apr 28, 2025 Risk: low
  Marex Group plc announced on April 25, 2025, that Henry Richards has resigned from its Board of Directors, effective immediately. Mr. Richards also stepped down
• Marex Group Files F-1 for Share Offering — 6-K · Apr 14, 2025 Risk: medium
  Marex Group plc announced on April 14, 2025, the filing of a registration statement on Form F-1 with the SEC for a proposed offering of ordinary shares by certa
• Marex Group plc Schedules Annual General Meeting for May 28 — 6-K · Apr 2, 2025 Risk: low
  Marex Group plc announced on April 2, 2025, that its Annual General Meeting of Shareholders will be held on May 28, 2025. The company has filed its Notice of An
• Marex Group plc Announces Preliminary Q1 Results, Investor Day — 6-K · Apr 2, 2025 Risk: low
  Marex Group plc announced preliminary Q1 results and an investor day on April 2, 2025. The company, headquartered in London, is a global financial services firm
• Marex Group plc Files 2024 Annual Report — 20-F · Mar 21, 2025 Risk: medium
  Marex Group plc filed its 20-F for the fiscal year ending December 31, 2024. The filing provides a comprehensive overview of the company's financial performance
• Marex Group plc Reports Q4 and Full Year 2024 Results — 6-K · Mar 6, 2025 Risk: low
  Marex Group plc announced its Fourth Quarter and Full Year 2024 results on March 6, 2025. The company, incorporated in the UK, is a security and commodity broke
• Marex Group Director Resigns — 6-K · Dec 19, 2024 Risk: low
  Marex Group plc announced on December 18, 2024, that Madelyn Antoncic has resigned from its Board of Directors. She also stepped down from her roles on the Nomi
• SC 13G Filing — SC 13G · Nov 14, 2024
• SC 13G Filing — SC 13G · Nov 14, 2024
• Marex Group plc Reports Q3 2024 Results — 6-K · Nov 7, 2024 Risk: low
  Marex Group plc announced its third quarter 2024 results on November 7, 2024. The company is a foreign private issuer filing a Form 6-K report with the SEC. The
• Marex Group plc Issues $600M in Senior Notes Due 2029 — 6-K · Nov 4, 2024 Risk: medium
  On November 4, 2024, Marex Group plc completed a public offering of $600,000,000 in aggregate principal amount of its 6.404% Senior Notes due 2029. This offerin
• Marex Group Files F-1 for Share Offering — 6-K · Oct 21, 2024 Risk: low
  Marex Group plc announced on October 21, 2024, that it filed a registration statement on Form F-1 with the SEC for a proposed offering of ordinary shares by cer
• Marex Group plc Reports Interim 2024 Results — 6-K · Aug 14, 2024 Risk: low
  Marex Group plc announced its Interim 2024 Results on August 14, 2024. The company, incorporated in the UK, filed a Form 6-K to report these earnings. The filin
• Marex Group plc Releases 2023 Results & Q1 2024 Update — 6-K · May 16, 2024 Risk: low
  Marex Group plc announced its full-year 2023 results and provided a Q1 2024 update on May 16, 2024. The company also published its UK Annual Report for 2023 on

Risk Profile

Risk Assessment: Of MRX's 26 recent filings, 0 were flagged as high-risk, 4 as medium-risk, and 22 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

• Chief Executive Officer
• Roger Nagioff
• Henry Richards
• Madelyn Antoncic

Top Tags

earnings (7) · sec-filing (5) · regulatory-filing (3) · prospectus-supplement (3) · securities-offering (3) · foreign-issuer (3) · annual-report (3) · financial-results (3) · financial-reporting (3) · registration-statement (3)

Key Numbers

• File Size: 26274 — Size of the complete submission text file in bytes
• Document Size: 5.7MB — Size of the primary prospectus supplement PDF document (tm267815d16_424b2.pdf)
• File Number: 333-289203 — Associated with the Act 33 filing for Marex Group plc
• SEC File Number: 001-42020 — Identifies Marex Group plc's filings with the SEC.
• Form S-8 File Number: 333-278953 — Registration statement for employee stock plans.
• Form F-3 File Number: 333-286884 — Registration statement for public offerings.
• First Quarter 2025: Q1 2025 — Period for which strong results were announced
• Senior Notes Issued: $500.0M — Aggregate principal amount of 5.829% Senior Notes due 2028
• Interest Rate: 5.829% — Coupon rate on the Senior Notes due 2028
• Maturity Date: 2028 — Year the Senior Notes are due
• Fiscal Year End: 2024-12-31 — The period covered by the financial statements.
• Filing Date: 2025-03-21 — The date the 20-F was submitted to the SEC.
• Senior Notes Interest Rate: 6.404% — The coupon rate on the newly issued debt.

Frequently Asked Questions